Cardiovascular Abnormalities in Carbon Monoxide Poisoning
Jalaj Garg1, Parasuram Krishnamoorthy2, Chandrasekar Palaniswamy1
1Division of Cardiology, Department of Internal Medicine, Westchester Medical Center, New York Medical College, Valhalla, NY.
American Journal of Therapeutics
|February 13, 2014
Summary
Acute carbon monoxide (CO) poisoning is a leading cause of death, causing diverse symptoms and cardiac issues. This review explores cardiovascular effects and proposes a management algorithm for CO poisoning.
Area of Science:
- Toxicology
- Cardiology
- Emergency Medicine
Background:
- Carbon monoxide (CO) poisoning is a frequent cause of accidental death in the US.
- CO poisoning presents with a wide range of symptoms, from mild to severe, including neurological and cardiovascular effects.
- Cardiovascular complications like myocardial ischemia and arrhythmias are significant concerns, contributing to mortality.
Purpose of the Study:
- To conduct a comprehensive literature review on the cardiovascular manifestations of acute carbon monoxide poisoning.
- To propose a diagnostic and management algorithm for patients with CO poisoning, focusing on cardiac injury.
Main Methods:
- Systematic review of existing literature on carbon monoxide poisoning and its cardiovascular effects.
- Analysis of reported cardiovascular complications, including myocardial stunning, dysfunction, and ischemia.
- Evaluation of current therapeutic strategies, such as supplemental oxygen and hyperbaric oxygen therapy.
Main Results:
- Carboxyhemoglobin (COHb) levels are not reliable indicators of clinical severity.
- Cardiovascular toxicity from CO exposure is linked to increased short- and long-term mortality.
- The efficacy of hyperbaric oxygen therapy in mitigating cardiac injury remains uncertain.
Conclusions:
- Cardiovascular manifestations are a critical aspect of CO poisoning, impacting patient outcomes.
- A structured diagnostic approach is needed to manage patients with suspected CO poisoning and cardiac involvement.
- Further research is required to clarify the role of hyperbaric oxygen in preventing or reversing CO-induced cardiac damage.
More Related Videos
Related Concept Videos
Cardiovascular System Abnormal Findings I: Inspection and Palpation
1.3K
In a cardiovascular examination, inspection and palpation are crucial for identifying abnormalities.
Abnormal findings observed during an inspection
Abnormal findings observed during an inspection
1.3K
Hypoxia
2.4K
Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
2.4K
Cardiovascular System Abnormal Findings II: Auscultation
858
Auscultation, an essential part of a heart examination, is done using a stethoscope. It provides crucial information about heart function and possible heart problems. Due to heart problems, abnormal sounds can be heard during systole or diastole. These sounds include S3 and S4 gallops, opening snaps, systolic clicks, and murmurs.
Abnormal Heart Sounds
Gallops:
Abnormal Heart Sounds
Gallops:
858
Acute Respiratory Failure-III
1.3K
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
1.3K
Coronary Artery Disease III: Clinical Manifestations
620
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
620
Acute Respiratory Failure-II
1.8K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.8K


